Hinge Health, Inc. (Ticker: HNGE US) is a US company specializing in musculoskeletal care, using AI and technology to automate the delivery of care for joint and muscle health. Hinge Health plans its IPO on the NYSE on May 22, 2025, offering 13.67 million shares within a $28.00-$32.00 price range, aiming to raise approximately $410.0 million if priced at the $30.00 midpoint. Of these shares, Hinge Health is offering 8.52 million, while selling shareholders are offering 5.14 million. The company's platform utilizes AI-powered motion tracking and a proprietary wearable device. The IPO is reportedly managed by firms including Morgan Stanley, Barclays, and BofA Securities. Hinge Health's estimated market capitalization upon listing is $2.34 billion.